Pacira BioSciences
$24.79
23
+$0.1+0.41% Tuesday 20:00
Statistics
Day High
25.6
Day Low
24.74
52W High
27.22
52W Low
19.16
Volume
694,236
Avg. Volume
-
Mkt Cap
1B
P/E Ratio
189.92
Dividend Yield
-
Dividend
-
Upcoming
Earnings
4AugExpected
Expected EPS
0.661429
Actual EPS
N/A
Financials
0.97%Profit Margin
Profitable1.45BRevenue
14.07MNet Income
Analyst Ratings
29.4Average Price Target
The highest estimate is 38.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 60%
Hold 40%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PCRX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Abbvie
ABBV
Mkt Cap365.43B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
AMGEN
AMGN
Mkt Cap178B
Merck
MRK
Mkt Cap277.02B
Novartis
NVS
Mkt Cap279.67B
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
About
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Show more...
CEO
Mr. Frank D. Lee
Employees
788
Country
United States
ISIN
US6951271005
Listings
0 Comments
Share your thoughts
FAQ
What is Pacira BioSciences stock price today?▼
The current price of PCRX is $24.79 USD — it has increased by +0.41% in the past 24 hours. Watch Pacira BioSciences stock price performance more closely on the chart.
What is Pacira BioSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pacira BioSciences stocks are traded under the ticker PCRX.
Is Pacira BioSciences stock price growing?▼
PCRX stock has fallen by -1.39% compared to the previous week, the month change is a +11.32% rise, over the last year Pacira BioSciences has showed a -1.43% decrease.
What is Pacira BioSciences market cap?▼
Today Pacira BioSciences has the market capitalization of 1B
When is the next Pacira BioSciences earnings date?▼
Pacira BioSciences is going to release the next earnings report on August 04, 2026.
What were Pacira BioSciences earnings last quarter?▼
PCRX earnings for the last quarter are 0.6 USD per share, whereas the estimation was 0.55 USD resulting in a +9.57% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pacira BioSciences revenue for the last year?▼
Pacira BioSciences revenue for the last year amounts to 1.45B USD.
What is Pacira BioSciences net income for the last year?▼
PCRX net income for the last year is 14.07M USD.
How many employees does Pacira BioSciences have?▼
As of May 06, 2026, the company has 788 employees.
In which sector is Pacira BioSciences located?▼
Pacira BioSciences operates in the Health & Wellness sector.
When did Pacira BioSciences complete a stock split?▼
Pacira BioSciences has not had any recent stock splits.
Where is Pacira BioSciences headquartered?▼
Pacira BioSciences is headquartered in Brisbane, United States.